Recro Pharma Stock Price (NASDAQ:REPH)

Add to My Stocks
$7.84 $0 (0%) REPH stock closing price Jul 26, 2017 (Closing)
Prev Close* : $7.84
Market Cap:
Day Low: $7.75
52 Week Low: $5.81
Open: $7.84
Volume: 50849
Day High: $7.86
52 Week High: $12.50

Latest Stock Market News

Latest Articles

Recro Pharma News - From Partners

Recro Pharma Reports Inducement Grants for New Staff   by Globe Newswire on Jun 15, 2017

REPH Stockcharts

View REPH PE ratio, PS ratio stocks charts and compare with peers.
REPH Chart
Note: Compare Recro Pharma stock price history with the index and industry peers.

Recro Pharma Valuation

PS ratio (
price to sales ratio
PB ratio (
price to book ratio

Recro Pharma Financial Ratios

Asset Turnover
Receivables Turnover
Debt to Equity

REPH Industry Peers

Company Price Change (%)
Summit Therapeutics (SMMT)13.70.7 (5.38%)
Redhill Biopharma (RDHL)10.440.06 (0.57%)
Catalent (CTLT)35.390.29 (0.81%)
Elite Pharma (ELTP)0.120 (0%)
Zogenix (ZGNX)12.850.15 (1.15%)
Trevena (TRVN)2.720.1 (3.55%)
Pernix Therapeutics (PTX)3.150.3 (8.7%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Arrowhead Pharma (ARWR)1.880.28 (17.5%)
Tetraphase Pharmaceuticals (TTPH)7.880.98 (14.2%)
Catalyst Pharma (CPRX)3.140.1 (3.29%)
Genocea Biosciences (GNCA)6.170.17 (2.83%)
GlycoMimetics (GLYC)11.970.31 (2.66%)
Shire (SHPG)169.83.69 (2.22%)
MEI Pharma (MEIP)3.050.06 (2.01%)
Top gainers from Medical-Drugs industry
* As of Jul 27, 2017
CompanyPriceChange (%)
USANA Health Sciences (USNA)57.457.3 (11.27%)
Adamis Pharma (ADMP)4.60.15 (3.16%)
AcelRx Pharma (ACRX)3.70.1 (2.63%)
Concert Pharma (CNCE)15.50.39 (2.45%)
Pacira Pharma (PCRX)41.6251.03 (2.42%)
Cardiome Pharma (CRME)4.530.11 (2.37%)
Aerie Pharma (AERI)54.71.25 (2.23%)
Top losers from Medical-Drugs industry
* As of Jul 27, 2017

Recro Pharma Inc Stock News - Partner Headlines

Recro Pharma Financial Statements

income statement2016201520142013
Net Sales Or Revenues69.33M51.95M--
Net Income-30.2M3.03M-16.13M-1.95M
Total Operating Expense57.94M30.86M11.86M1.08M
view Recro Pharma Inc income statement
balance sheet2016201520142013
Total Assets182.99M138.69M20.37M0.85M
Total Liabilities111.38M98.34M1.44M12.93M
Shareholders Equity71.61M40.35M18.92M-12.07M
view Recro Pharma Inc balance sheet
cash flow statement2016201520142013
Net Increase (Decrease) In Assets Liabilities6.53M7.64M0.46M0.27M
Net Cash From (Used By) Operating Activities-3.2M8.45M-10.86M-0.81M
Increase (Decrease) In Prop Plant And Equipment-3.77M-2.41M--
view Recro Pharma Inc cashflow statement

Recro Pharma Stock Message Board

An investor needs to spend 7.84 to buy REPH stock, as the closing Recro Pharma stock price is 7.84. Stock price or share price can be used to find the total market value of a company. Recro Pharma market cap stands at 149.39M as of 26 Jul, 2017. Recro Pharma valuation can be different from its intrinsic stock price when viewed from a value investors perspective.

Demand for a stock decides its stock market price. For example, if more investors want to buy REPH stock than sell it, then Recro Pharma stock price goes up. Conversely, if more investors wanted to sell REPH stock than buy it, there would be greater supply than demand, and the stock price would fall. The volume number in Recro Pharma stock quote data shows the number of shares traded. For Ex: 50849 Recro Pharma shares were traded as of last trading day, as seen from Recro Pharma stock chart. A dividend is a cash payment from a company's earnings and is distributed among shareholders. Recro Pharma does not pay dividends. To check the historical stock price movement, all time high, and all time low of REPH, view Recro Pharma stock price history.